Saúde Pública/Medicina Humanitária
COVID-19 em 2022: o controle da pandemia está ao nosso alcance.
15 Dez, 2021 | 12:38hCOVID-19 in 2022: controlling the pandemic is within our grasp – Nature Medicine
Comentários no Twitter
What will the COVID-19 pandemic look like in 2022?
Who better to ask than @mvankerkhove, one of the busiest people in the world right now, who took the time to write this thoughtful World View for @NatureMedicine.https://t.co/jgodgPIDrK
— Ben Johnson 🦠📝 (@drbenjohnson) December 14, 2021
Vaccine inequity, inconsistent public health measures and new variants such as Omicron are prolonging the COVID-19 pandemic, but controlling the virus remains possible.
Worldview from @mvankerkhove @WHOhttps://t.co/vLmASqI8i7
— Nature Medicine (@NatureMedicine) December 14, 2021
Ômicron: apresentação técnica atualizada da OMS e ações de prioridade.
14 Dez, 2021 | 16:20h
Comentário no Twitter (fio – clique para saber mais)
🆕 Technical Brief & Priority Actions for Member States on enhancing readiness for Omicron https://t.co/tOu6iIvFZP #COVID19 pic.twitter.com/huPP4QFS35
— World Health Organization (WHO) (@WHO) December 12, 2021
Recomendações para uma recuperação equitativa da pandemia de COVID-19 no Canadá.
14 Dez, 2021 | 16:16hComunicado de imprensa: Equitable COVID-19 pandemic recovery in Canada: New guideline – Canadian Medical Association Journal
Editorial: Build back more equitably
[Preprint] Variante Ômicron do SARS-CoV-2 escapa da neutralização via soro de pessoas vacinadas e convalescentes.
14 Dez, 2021 | 16:15hComentário: SARS-CoV-2 omicron variant may evade host immune responses – News Medical
Comentário no Twitter (fio – clique para saber mais)
⚠️OMICRON “EVADES” NEUTRALIZATION—1st ever #Omicron variant study of blood from Moderna, Oxford-AstraZeneca, Pfizer vaccinated, vs survivors of Alpha, Beta, Delta variants. Omicron #B11529 evasive—but 2x Pfizer/mixed stronger>> convalescent; 3x hit best.🧵 https://t.co/292o740rHy pic.twitter.com/NYei6MACkj
— Eric Feigl-Ding (@DrEricDing) December 13, 2021
[Preprint] Vacinas contra COVID eliminam o risco de transmissão da variante Delta – mas não por muito tempo.
14 Dez, 2021 | 16:12hCOVID vaccines cut the risk of transmitting Delta — but not for long – Nature
Estudo original [preprint]: The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission – medRxiv
Relatório OMS | Mais de meio bilhão de pessoas foram empurradas para a pobreza extrema em decorrência dos custos do cuidado de saúde.
14 Dez, 2021 | 16:10hComunicado de imprensa: More than half a billion people pushed or pushed further into extreme poverty due to health care costs – World Health Organization
Relatório 1: Tracking Universal Health Coverage: 2021 Global monitoring report – World Health Organization
Relatório 2: Global monitoring report on financial protection in health 2021 – World Health Organization
Relatório OMS | Salvar vidas, desperdiçar menos: o investimento em doenças não comunicantes.
14 Dez, 2021 | 16:09hComunicado de imprensa: Investing 1 dollar per person per year could save 7 million lives in low and lower-middle income countries – World Health Organization
Comentário no Twitter
🆕 WHO report shows that investing only 1⃣ USD per person per year in the prevention and control of noncommunicable diseases could save almost 7⃣ million lives 🌍 by 2030. Let's #BeatNCDs!https://t.co/KP71n5M1cY pic.twitter.com/kviaoWc2J5
— World Health Organization (WHO) (@WHO) December 13, 2021
Perspectiva | Prejuízo relacionado ao álcool é uma questão de saúde pública, não uma escolha de estilo de vida.
14 Dez, 2021 | 15:59hAlcohol-related harm is a public health issue, not a lifestyle choice – Health Policy Watch
Conteúdos relacionados:
COVID-19 pandemic and alcohol consumption: Impacts and interconnections – Toxicology Reports
National, Regional, and Global Burdens of Disease Attributable to Alcohol Use
Study: Alcohol Use and Burden for 195 Countries and Territories
Study: The Global Burden of Disease Attributable to Alcohol and Drug Use
Study: Global Alcohol Exposure Between 1990 and 2017 and Forecasts Until 2030
Analysis: Prioritizing Action on Alcohol for Health and Development
Research: Contribution of alcohol use disorders to the burden of dementia
Relatório do Reino Unido sobre as variantes de preocupação do SARS-CoV-2 mostra efetividade da vacina (EV) significativamente menor contra infecção pela Ômicron, porém uma EV moderada a alta (70 a 75%) após uma terceira dose (reforço).
13 Dez, 2021 | 11:43hComentários:
Omicron: Three vaccine doses key for protection against variant – BBC
Two jabs offer little protection against Omicron infection, UK data shows – The Guardian
UK Says Omicron to Become Its Dominant Variant Within Days – Associated Press
Estudo observacional mostrou que a vacina da Moderna está associada com efetividade aumentada, em comparação com a vacina da Pfizer, contra infecção sintomática por SARS-CoV-2.
13 Dez, 2021 | 11:41hComparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection – Med
Conteúdos relacionados:
Opinion | Is Moderna really better than Pfizer—or is it just a higher dose?
Comentário no Twitter
New @MedCellPress
Comparative effectiveness of the Pfizer and Moderna vaccines over time, in both the Alpha and Delta US waves, vs symptomatic infections https://t.co/RlWUXeZ2f2
consistent 8-12 % points advantage for Moderna pic.twitter.com/IwHXFIKaEp— Eric Topol (@EricTopol) December 11, 2021


